Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...
Twice the output, half the runtime, and half the footprint of the UG 100® with greater flexibility and improved genomic ...
mamba env create -f env.yml mamba activate mofflow-2 pip install git+https://github.com/microsoft/MOFDiff.git pip install -e . Note: If you want to build your own ...
Abstract: Random instruction sequence (RIS) tools are widely used across the industry for processor verification and validation. These tools are often used to find design bugs in a relatively stable ...
Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...
Abstract: Recent studies on sign language recognition (SLR) mainly focus on deaf individuals communicating with those who can hear. However, less attention has been given to enable hearing individuals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results